Diabetes, Digestive, and Kidney Diseases Extramural Research in Washington
Diabetes, Digestive, and Kidney Diseases Extramural Research (93.847) awarded $237 million to recipients in Washington in 161 grants from fiscal 2021 to 2025, 2.5% of the program's national total. University of Washington received the most, $130 million.
- Awarded in Washington$237 million
- Awards161
- Share of the program2.5%
- Rank among states16th of 51
- National total$9.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 87 | $45.4 million |
| FY 2022 | 93 | $48.3 million |
| FY 2023 | 90 | $47.5 million |
| FY 2024 | 82 | $45.8 million |
| FY 2025 | 79 | $50.5 million |
Recipients in Washington
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of Washington | Colleges and universities | 97 | $130 million |
| Benaroya Research Institute at Virginia Mason | Nonprofits | 8 | $28.1 million |
| Seattle Children's Hospital | Nonprofits | 19 | $27.9 million |
| Fred Hutchinson Cancer Center | Nonprofits | 9 | $16.0 million |
| Battelle Memorial Institute | Nonprofits | 4 | $7.2 million |
| Pharmain Corporation | Small businesses | 1 | $6.8 million |
| Institute for Systems Biology | Nonprofits | 2 | $5.4 million |
| Seattle Institute for Biomedical and Clinical Research | Nonprofits | 4 | $4.9 million |
| Washington State University | Colleges and universities | 5 | $2.7 million |
| Liver Institute Northwest PLLC | Small businesses | 1 | $1.6 million |
Open opportunities under this program
- Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Diabetes Research Centers (P30 Clinical Trial Optional)
- Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
See all 68 on the program page
Questions people ask
How much Diabetes, Digestive, and Kidney Diseases Extramural Research money goes to Washington?
$237 million from fiscal 2021 to 2025, across 161 awards. Washington ranks 16th of 51 states and territories for this program.
Who receives Diabetes, Digestive, and Kidney Diseases Extramural Research money in Washington?
The largest recipient is University of Washington, with $130 million in 97 awards. Next are Benaroya Research Institute at Virginia Mason and Seattle Children's Hospital.
Can organizations in Washington apply now?
Yes, 68 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Diabetes, Digestive, and Kidney Diseases Extramural Research in other states
Other large programs in Washington
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Federal Transit Formula Grants
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Temporary Assistance for Needy Families
- National School Lunch Program
- Federal Transit Capital Investment Grants
- Allergy and Infectious Diseases Research
- Child Care and Development Block Grant